Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions
1 other identifier
interventional
9
1 country
1
Brief Summary
Family Medicine patients with uncontrolled hypertension will be given a Bluetooth enabled home blood pressure machine to monitor their blood pressure every day for 6 weeks. The blood pressure results will be sent automatically to the patient's electronic medical record via applications on their iPhone. Study pharmacists will follow-up with the patients once per week via a telehealth appointment using the app VSee, where the blood pressure results will be reviewed. The pharmacists will also counsel the patients on lifestyle modifications in order to improve blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Jan 2019
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 23, 2019
CompletedFirst Submitted
Initial submission to the registry
March 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedFirst Posted
Study publicly available on registry
November 7, 2022
CompletedNovember 7, 2022
January 1, 2019
3 months
March 26, 2019
November 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Comfort
Patient comfort in using home telemonitoring for blood pressure combined with pharmacist counseling and monitoring will be measured using a survey instrument with a Likert scale (4-point scale). (Most of the time; Some of the time; Seldom; Never) (Strongly agree; Agree; Disagree; Strongly disagree) (Nothing; Very little; Some; Knowledgeable)
8 weeks
Secondary Outcomes (1)
Determine if pharmacists' interventions improved BP
8 weeks
Study Arms (1)
Home blood pressure monitoring
EXPERIMENTAL* Smart Phones with Apple Health Software will be used to monitor blood pressure once a day, and results will be sent automatically to the patients EHR (Epic) * The Omron 10 Series Wireless Upper Arm Blood Pressure Device will be given to the patient to monitor blood pressure at home daily * Patients will be scheduled for a one-hour in-person appointment for the initial study visit where informed consent will be obtained, and for the final study visit
Interventions
• Follow-up with patients once per week for six (6) weeks via scheduled 20-minute telehealth appointment with each patient via the HIPAA secure and compliant platform, VSee o During this telehealth appointment, the study pharmacists will counsel the patients on their blood pressure readings for that week and provide lifestyle education focusing on patient-specific diet and exercise recommendations
A pre- and post-survey will be given at the initial and final in-person appointments, respectively • These surveys will collect basic patient demographics, knowledge of blood pressure, comfort with checking blood pressure at home, and previous experience working with a pharmacist
Smart Phones with Apple Health Software will be used to monitor blood pressure once a day, and results will be sent automatically to the patients EHR (Epic) • The Omron 10 Series Wireless Upper Arm Blood Pressure Device will be given to the patient to monitor blood pressure at home daily
Eligibility Criteria
You may qualify if:
- must be at least 18 years old
- have a smartphone compatible with the mobile intervention (iPhone)
- have been previously diagnosed with hypertension
- have uncontrolled hypertension (SBP \> 130 mmHg and/or DBP \> 80 mmHg)
- be under the care of a primary care physician in the Family Medicine Department of the USF Morsani Center for Advanced Care
- have had at least one prescription filled at Pharmacy Plus within the last six months
- speaks English fluently
You may not qualify if:
- already under the care of a clinical pharmacist in the Family Medicine department
- pregnant
- have a serious existing medical condition(s) that may affect their ability to self-monitor their blood pressure (for example, stroke, dementia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USF Pharmacy Plus
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wendy H Updike, PharmD
University of South Florida College of Pharmacy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2019
First Posted
November 7, 2022
Study Start
January 23, 2019
Primary Completion
April 30, 2019
Study Completion
June 30, 2019
Last Updated
November 7, 2022
Record last verified: 2019-01